Secondary prevention and follow-up of patients with ACS and not-at-target LDL: An Italian real-world retro-prospective analysis by the inertia group

BACKGROUND: In patients with recent ACS, the latest ESC/EAS guidelines for management of dyslipidaemia recommend intensification of LDL-C-lowering therapy. OBJECTIVE: Report a real-world picture of lipid-lowering therapy prescribed and cholesterol targets achieved in post-ACS patients before and aft...

Descripción completa

Detalles Bibliográficos
Autores principales: Del Pinto, Maurizio, Amico, Francesco, Brunetti, Natale, Caldarola, Pasquale, Carugo, Stefano, Cavallini, Claudio, D'Andrea, Antonello, Fedele, Francesco, Mauro, Ciro, Noussan, Patrizia, Paloscia, Leonardo, Prati, Francesco, Tarzia, Pierpaolo, Tespili, Maurizio, Barbieri, Lucia, Basso, Pierangelo, Buono, Andrea, D'Alleva, Alberto, Giubilato, Simona, Iannacone, Mario, Ferrante, Fabio, Granata, Giuseppina, Ieva, Riccardo, Madrid, Alfredo, Mallus, Maria Teresa, Tagliamonte, Ercole
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9984953/
https://www.ncbi.nlm.nih.gov/pubmed/36879560
http://dx.doi.org/10.1016/j.ijcrp.2023.200181

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9984953/
https://www.ncbi.nlm.nih.gov/pubmed/36879560
http://dx.doi.org/10.1016/j.ijcrp.2023.200181

Ejemplares similares